nonsense. BTX 1503 will almost certainly proceed into phase 3 trials.
Phase 2 trials focus on: safety, dosage/regimen, efficacy, and: to resolve uncertainties regarding the design and conduct of subsequent trials
safety aced, preferred dosage/regimen selected, efficacy is better than zero, issues with ph2 trial identified.
these trials are not intended or expected to produce flawless results, it's a process. - gate passed, next test.
BOT price action, page-1425
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.8¢ | 27.8¢ | $2.808M | 9.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2857 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 77213 | 2 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.3¢ |
Change
-0.005 ( 2.72 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 30.5¢ | 27.8¢ | 3452172 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| BOT (ASX) Chart |